We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.72B
1-Year Est. Return 25.63%
This Fund
S&P 500
This Quarter Est. Return
-10.75%
1 Year Est. Return
+25.63%
3 Year Est. Return
+82.02%
5 Year Est. Return
+99.95%
10 Year Est. Return
+300.08%
AUM
$789M
AUM Growth
-$76.5M
Cap. Flow
+$30M
Cap. Flow %
3.8%
Top 10 Hldgs %
27.06%
Holding
1,208
New
169
Increased
297
Reduced
314
Closed
91

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$6.75M
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$5.08M
3
AZN icon
AstraZeneca
AZN
+$4.62M
4
MDT icon
Medtronic
MDT
+$2.43M
5
BKNG icon
Booking.com
BKNG
+$2.36M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.36M
2
TSN icon
Tyson Foods
TSN
+$4.6M
3
BAC icon
Bank of America
BAC
+$4.41M
4
HAS icon
Hasbro
HAS
+$3.88M
5
USB icon
US Bancorp
USB
+$3.09M

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.92%
2 Technology 13.04%
3 Healthcare 12.98%
4 Financials 11.51%
5 Consumer Staples 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
926
BioCryst Pharmaceuticals
BCRX
$2.22B
$1K ﹤0.01%
+100
New +$1.03K
BEAM icon
927
Beam Therapeutics
BEAM
$2.58B
$1K ﹤0.01%
+25
New +$994
BHC icon
928
Bausch Health
BHC
$2.12B
$1K ﹤0.01%
100
– –
BKCH icon
929
Global X Blockchain ETF
BKCH
$308M
$1K ﹤0.01%
50
+28
+127% +$1.09K
BUD icon
930
AB InBev
BUD
$153B
$1K ﹤0.01%
+19
New +$1.07K
BYND icon
931
Beyond Meat
BYND
$198M
$1K ﹤0.01%
+1
New +$959
CGNT icon
932
Cognyte Software
CGNT
$621M
$1K ﹤0.01%
311
-30
-9% -$210
CLF icon
933
Cleveland-Cliffs
CLF
$7.13B
$1K ﹤0.01%
56
– –
CMBM
934
DELISTED
Cambium Networks
CMBM
$1K ﹤0.01%
44
– –
COHR icon
935
Coherent
COHR
$62.1B
$1K ﹤0.01%
+25
New +$1.52K
CPRT icon
936
Copart
CPRT
$27.1B
$1K ﹤0.01%
48
+4
+9% +$114
CVNA icon
937
Carvana
CVNA
$46.9B
$1K ﹤0.01%
260
+170
+189% +$1.79K
DH icon
938
Definitive Healthcare
DH
$102M
$1K ﹤0.01%
55
-43
-44% -$920
DOCS icon
939
Doximity
DOCS
$4.65B
$1K ﹤0.01%
+38
New +$1.5K
DOCU
940
DocuSign
DOCU
$12.9B
$1K ﹤0.01%
20
+15
+300% +$1.21K
DRI icon
941
Darden Restaurants
DRI
$23.8B
$1K ﹤0.01%
12
-3
-20% -$375
DSGN icon
942
Design Therapeutics
DSGN
$766M
$1K ﹤0.01%
+44
New +$594
DXC icon
943
DXC Technology
DXC
$1.72B
$1K ﹤0.01%
19
– –
ERIC icon
944
Ericsson
ERIC
$33.2B
$1K ﹤0.01%
100
+29
+41% +$237
EVTC icon
945
Evertec
EVTC
$1.65B
$1K ﹤0.01%
30
-7
-19% -$267
FFWM
946
DELISTED
First Foundation Inc
FFWM
$1K ﹤0.01%
47
– –
GDRX icon
947
GoodRx Holdings
GDRX
$1.15B
$1K ﹤0.01%
+150
New +$1.67K
GNTX icon
948
Gentex
GNTX
$4.69B
$1K ﹤0.01%
47
-12
-20% -$349
GOSS icon
949
Gossamer Bio
GOSS
$65.6M
$1K ﹤0.01%
+1
New +$620
GTLS
950
DELISTED
Chart Industries
GTLS
$1K ﹤0.01%
8
– –
36 37
38
39 40

Similar funds

PIMG
Patriot Investment Management Group Knoxville, Tennessee $1.72B AUM 17.84% 1-Year Est. Return
SIM
SSI Investment Management Los Angeles, California $1.72B AUM 7.09% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.72B AUM 20.41% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.73B AUM 9.28% 1-Year Est. Return

Howe & Rusling's Q2 2022 Portfolio in Review

As of Q2 2022, Howe & Rusling held 1,208 positions worth $789M, down 8.8% from $865M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Howe & Rusling deployed $30M of net new capital in Q2 2022, opening 169 new positions and adding to 297 existing holdings. Its largest new stake was AstraZeneca: 35,197 shares worth $4.65M.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $9.36M trimmed.

  • Howe & Rusling's largest Q2 2022 buy was AstraZeneca: 35,197 shares worth $4.65M.
  • Howe & Rusling added most to Lowe's Companies in Q2 2022, an estimated $6.75M increase.
  • Howe & Rusling's biggest Q2 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $9.36M.
  • Howe & Rusling fully exited Traeger in Q2 2022, selling an estimated $124K.
  • Howe & Rusling's ten largest holdings make up 27% of its $789M portfolio in Q2 2022.
  • Howe & Rusling opened 169 new positions and closed 91 in Q2 2022.
  • Howe & Rusling's portfolio value fell 8.8% quarter-over-quarter to $789M.

Based on Howe & Rusling's 13F filing for Q2 2022, filed 15 Aug 2022.